Clinical Trial Update: Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating intravenous alpha-1 antitrypsin in hospitalized patients with COPD exacerbations; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Alpha-1 Antitrypsin (intravenous) (alpha-1 antitrypsin)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Acute Exacerbation Chronic Obstructive Pulmonary Disease | Phase 2 | Status: NOT_YET_RECRUITING